Cargando…
Anti-TNF-Alpha Therapy and Systemic Vasculitis
TNF-α is a pleiotropic cytokine, which plays a major role in the pathogenesis of numerous autoimmune and/or inflammatory systemic diseases. Systemic vasculitis constitutes a group of rare diseases, characterized by inflammation of the arterial or venous vessel wall, causing stenosis and thrombosis....
Autores principales: | Jarrot, Pierre-André, Kaplanski, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955590/ https://www.ncbi.nlm.nih.gov/pubmed/24719524 http://dx.doi.org/10.1155/2014/493593 |
Ejemplares similares
-
The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update
por: Chiche, Laurent, et al.
Publicado: (2012) -
Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis
por: Jarrot, Pierre-Andre, et al.
Publicado: (2016) -
Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome
por: Arcani, Robin, et al.
Publicado: (2023) -
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
por: Leone, Gian Marco, et al.
Publicado: (2023) -
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy
por: Cestelli, Valentina, et al.
Publicado: (2014)